Share on StockTwits

Investment analysts at Sterne Agee upped their price objective on shares of Endo International PLC (NASDAQ:ENDP) from $1.00 to $75.00 in a note issued to investors on Thursday. Sterne Agee’s target price indicates a potential upside of 10.91% from the stock’s previous close.

Endo International PLC (NASDAQ:ENDP) traded up 0.81% during mid-day trading on Thursday, hitting $67.62. 2,445,428 shares of the company’s stock traded hands. Endo International PLC has a 52-week low of $36.17 and a 52-week high of $82.16. The stock’s 50-day moving average is $68.43 and its 200-day moving average is $68.73. The company’s market cap is $11.047 billion.

Endo International PLC (NASDAQ:ENDP) last released its earnings data on Thursday, July 31st. The company reported $1.06 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.88 by $0.18. The company had revenue of $719.00 million for the quarter, compared to the consensus estimate of $644.60 million. During the same quarter in the prior year, the company posted $1.42 earnings per share. The company’s quarterly revenue was up .9% on a year-over-year basis. Analysts expect that Endo International PLC will post $3.96 EPS for the current fiscal year.

ENDP has been the subject of a number of other recent research reports. Analysts at Cantor Fitzgerald reiterated a “sell” rating on shares of Endo International PLC in a research note on Wednesday. They now have a $52.00 price target on the stock, up previously from $37.00. Separately, analysts at Deutsche Bank initiated coverage on shares of Endo International PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $81.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Tuesday, July 15th. They now have a $71.00 price target on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $73.60.

Endo International PLC, formerly Endo Health Solutions Inc, is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.